Fact-checked by Grok 2 weeks ago

Geranyl pyrophosphate

Geranyl pyrophosphate (GPP), also known as geranyl diphosphate, is an with the molecular formula C₁₀H₂₀O₇P₂, serving as a key intermediate in the mevalonate and methylerythritol phosphate (MEP) pathways of isoprenoid biosynthesis. It consists of a 10-carbon geranyl chain attached to a group, formed through the head-to-tail condensation of (DMAPP) and isopentenyl (IPP), a reaction catalyzed by geranyl pyrophosphate synthase enzymes. In cellular , GPP functions primarily as a precursor for the synthesis of monoterpenes, which are volatile compounds essential for plant defense, pollination, and aroma, as well as for the elongation to longer prenyl pyrophosphates such as (FPP) and (GGPP), which support , , and production across organisms. Its dysregulation is implicated in metabolic disorders, and GPP analogs are explored in for inhibiting enzymes like synthase to target biosynthesis or cancer-related . In plants, compartmentalization of GPP production in plastids versus directs its flux toward specific classes, highlighting its central role in metabolic diversity.

Chemical Identity

Molecular Structure

Geranyl pyrophosphate (GPP) is the pyrophosphate ester of , consisting of a branched 10-carbon isoprenoid esterified at the position with a diphosphate group. Its molecular formula is C₁₀H₁₇O₇P₂, corresponding to the trianionic form prevalent in biological contexts, with a of 311.19 g/. The IUPAC name is (2E)-3,7-dimethylocta-2,6-dien-1-yl trihydrogen diphosphate, reflecting the specific of the at C2–C3. The structure features a linear of eight carbons with methyl substituents at C3 and C7, a (E) between C2–C3, a between C6–C7, and the moiety (-O-P(O)(OH)-O-P(O)(OH)₂) linked via an oxygen to C1, forming an allylic system. The geranyl chain can be described as -CH₂(1)-CH(2)=C(3)(CH₃)-CH₂(4)-CH₂(5)-CH(6)=C(7)(CH₃)-CH₃(8), with the attached to C1. The allylic carbon at C1 is -CH₂-OP₂O₆H₃, adjacent to the = , which enhances leaving group potential of the during ionization. The E-configuration at the establishes the essential for the spatial arrangement in extended chains during . This distinguishes GPP from its neryl pyrophosphate and supports efficient chain elongation in isoprenoid assembly.

Nomenclature and Properties

Geranyl , commonly abbreviated as GPP, is systematically named (2E)-3,7-dimethylocta-2,6-dien-1-yl diphosphate. It is also referred to as geranyl diphosphate (GDP) or trans-geranyl , reflecting its role as the of the monoterpenoid alcohol . These names highlight the trans configuration at the C2-C3 and the C10 isoprenoid chain length. The compound typically exists as salts, such as the , , or triammonium forms, which appear as colorless solids or solutions. These salts exhibit limited in (slightly soluble, with concentrations up to >5 mg/mL in aqueous buffers), but they are more readily soluble in polar organic solvents like . The molecular formula is C₁₀H₂₀O₇P₂, with a molecular weight of 314.21 g/mol for the free acid form. Chemically, geranyl pyrophosphate contains a labile anhydride bond (P-O-P linkage) that stores high energy (approximately -7.3 kcal/mol under standard conditions), rendering it susceptible to nucleophilic attack and cleavage. This bond, combined with the allylic position of the geranyl chain, facilitates reactivity as an electrophilic in substitution reactions, where the diphosphate serves as an excellent . GPP demonstrates instability under acidic or basic conditions, undergoing to yield and inorganic via C-O bond scission. In neutral aqueous environments, it can slowly degrade through elimination pathways, forming or premyrcene-like products, particularly when trace metal ions like Mn²⁺ are present to catalyze the process. Storage as dry salts at low temperatures (-20°C) minimizes degradation, though exposure to moisture or pH extremes accelerates breakdown. Identification of GPP often relies on spectroscopic techniques, including ¹H NMR showing characteristic signals for the trans double bond (δ ≈ 5.4 , J ≈ 7 Hz) and methyl groups (δ ≈ 1.6-1.7 ), alongside ³¹P NMR peaks around -10 to -12 for the diphosphate moiety. () spectroscopy reveals strong absorptions for P-O stretches (≈ 1100-1200 cm⁻¹) and C=C bonds (≈ 1650 cm⁻¹).

Biosynthesis

Enzymatic Formation

Geranyl pyrophosphate (GPP) is synthesized through the head-to-tail condensation of dimethylallyl pyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP), the universal C5 isoprenoid precursors, to form the C10 product GPP and inorganic pyrophosphate (PPi). This reaction is catalyzed by geranyl pyrophosphate synthase (GPPS; EC 2.5.1.1), a member of the prenyltransferase family that exhibits strict chain-length specificity for C10 products in most cases. The overall reaction can be represented as: \text{DMAPP} + \text{IPP} \rightarrow \text{GPP} + \text{PP}_\text{i} The catalytic mechanism of GPPS follows a stepwise ionization-condensation-elimination pathway. Initially, the enzyme facilitates the ionization of DMAPP by dissociation of its pyrophosphate group, generating a resonance-stabilized allylic carbocation intermediate coordinated by Mg²⁺ ions. Subsequently, the C4 carbon of IPP's double bond performs a nucleophilic attack on the carbocation at the C1 position of DMAPP in an Sₙ1-like fashion, forming a new C-C bond. The process concludes with the stereospecific abstraction of the pro-R hydrogen from the C2 position of the IPP-derived moiety, yielding the trans-configured double bond in GPP and restoring the enzyme for further catalysis. The of GPPS features two conserved aspartate-rich motifs, typically DDxxD, which bind two Mg²⁺ ions to coordinate the pyrophosphate moieties of DMAPP and . Critical residues, such as Asp-83, Asp-84, Asp-89, Arg-94, Arg-95, and Lys-44 in the large subunit of ( piperita) GPPS, stabilize the and facilitate proton transfer. Chain-length specificity is enforced by a hydrophobic pocket lined with bulky residues like Phe-112 and Phe-113 in GPPS, which restrict further addition beyond C10. GPPS variants differ across organisms: monofunctional forms produce only GPP, while bifunctional enzymes can elongate to (FPP). In plants like (Mentha piperita), GPPS often assembles as a heterotetramer (LSU·SSU)₂, where the large subunit (LSU) provides catalytic activity and the small subunit (SSU) enhances specificity by forming regulatory loops that limit product chain length. In contrast, GPPS in some plants, such as Norway spruce (), may function as homodimers or bifunctional synthases integrated into broader pathways.

Integration in Isoprenoid Pathways

Geranyl pyrophosphate (GPP) integrates into isoprenoid biosynthetic networks as a central C10 intermediate, derived from the condensation of and , the universal C5 building blocks. These precursors originate upstream from two distinct pathways: the , which operates in the of eukaryotes and animals to generate from through a series of seven enzymatic steps, followed by to DMAPP; and the , which functions in the plastids of plants and throughout , producing IPP and DMAPP directly from pyruvate and in a balanced ratio. In , the MEP pathway serves as the exclusive source for these units, underscoring its essential role in prokaryotic isoprenoid metabolism. Organism-specific variations highlight the compartmentalized nature of these networks, particularly in , where dual pools of precursors exist: the cytosolic MVA pathway supports sesquiterpenoid and polyterpenoid synthesis, while the plastidial pathway fuels monoterpenoids and , with GPP bridging these compartments through limited metabolite exchange. Downstream, GPP extends the chain as a for farnesyl pyrophosphate synthase (FPPS), which catalyzes its condensation with an additional molecule to yield (FPP), a C15 precursor for longer isoprenoids. This sequential elongation exemplifies the modular architecture of isoprenoid pathways, enabling diverse product formation. Regulation of GPP integration occurs through feedback mechanisms, where downstream isoprenoids such as GPP and FPP inhibit upstream enzymes like mevalonate kinase, preventing precursor overaccumulation and maintaining flux balance. In microbial genomes, particularly those of species, isoprenoid biosynthetic genes are frequently clustered, promoting coordinated and evolution of specialized pathways. Evolutionarily, the prenyltransferases responsible for GPP formation and extension exhibit a conserved structural fold, including characteristic DDXXD motifs for metal ion coordination, across , , and animals, reflecting ancient origins and functional universality in isoprenoid assembly.

Biological Significance

Role as Terpenoid Precursor

Geranyl pyrophosphate (GPP) serves as the primary C10 prenyl intermediate in the biosynthetic pathway, acting as an essential precursor for the formation of monoterpenoids and contributing to the elongation of longer-chain isoprenoids. Synthesized by geranyl diphosphate synthase (GPPS) through the head-to-tail condensation of (DMAPP) and isopentenyl pyrophosphate (), GPP functions as a prenyl donor by transferring its geranyl moiety to acceptor molecules, including additional IPP units to generate (FPP) and subsequently (GGPP). This chain elongation process is crucial for producing higher s, such as derived from GGPP in plastids of like , where GPP flux supports pigment biosynthesis. Although GPP can participate in the geranylation of certain biomolecules, such as tRNA in prokaryotes, in eukaryotes GPP's role is primarily in terpenoid assembly, while protein is mediated by longer-chain prenyl pyrophosphates such as FPP and GGPP. In monoterpene synthesis, GPP undergoes ionization and cyclization catalyzed by monoterpene synthases (), yielding a diverse array of volatile compounds that serve ecological functions in . These enzymes initiate the reaction by cleaving the pyrophosphate group from GPP, forming a geranyl that rearranges into cyclic or acyclic structures, such as , , and . For instance, in ( piperita) trichomes, GPP-derived contributes to production, while in like Abies grandis, it leads to formation. Similarly, biosynthesis in relies on GPP as the direct substrate for TPS activity, highlighting its role in generating aromatic volatiles that deter herbivores and attract pollinators. Metabolic engineering efforts underscore the importance of GPP flux in production, with optimizations increasing precursor availability to boost yields. In engineered expressing the and mint limonene synthase, GPP flux enhancements achieved limonene titers of 605 mg/L, demonstrating scalable output. In , fusing GPPS with TPS enzymes has similarly elevated pinene production by channeling IPP/DMAPP toward GPP, though linker lengths influence efficiency. Genetic perturbations further reveal GPP's impact; in mutants lacking functional heteromeric GPPS subunits (e.g., GGPPS11 or GGPPS12), emissions in flowers dropped by 40-70%, altering volatile profiles and reducing total levels to as low as 631 peak area/mg fresh weight compared to wild-type controls. These deficiencies confirm GPPS as a , with overexpression restoring or enhancing diversity in model plants.

Antimicrobial Effects

Geranyl pyrophosphate (GPP) exhibits toxicity to bacterial cells, most notably Escherichia coli, where intracellular accumulation at moderate levels disrupts cellular function and inhibits growth. This toxicity manifests as reduced cell viability and metabolic imbalance, primarily through interference with the isoprenoid biosynthesis pathway. In engineered expressing the , GPP competitively binds to the ATP-binding site of mevalonate 5-kinase (M5K), inhibiting the enzyme and halting flux through the ; native utilize the methylerythritol phosphate () pathway instead. The mechanism of GPP-induced growth arrest involves both enzymatic inhibition and potential membrane perturbation, as evidenced by studies in engineered E. coli strains for production. Accumulation of GPP leads to feedback regulation that diverts resources from essential processes, resulting in stalled and decreased biomass. In applications, such as monoterpene biosynthesis, GPP toxicity is a key bottleneck, with cellular uptake studies showing rapid intracellular buildup that correlates with diminished growth rates compared to control strains. Longer-chain analogs like (FPP) display similar but often more pronounced effects. Experimental evidence highlights toxicity thresholds for GPP-related compounds in the range observed during pathway , where moderate doses (proxied by equivalents at ~0.05% v/v or 445 mg/L) significantly impair E. coli . In , downstream monoterpenoids derived from GPP contribute to defenses against pathogens. Bacterial resistance to prenyl pyrophosphate frequently involves efflux pumps, such as AcrAB-TolC, which export the compound and restore cellular in tolerant strains. A seminal 2013 study on production in E. coli identified key toxicity thresholds, demonstrating that unbalanced GPP levels lead to pathway inefficiency and arrest unless mitigated by optimized precursor supply. Recent efforts as of 2025 include strategies to counter GPP , such as efflux modulation, to enable stable production in E. coli.

Occurrence and Production

Natural Distribution

Geranyl pyrophosphate (GPP), a key C10 isoprenoid intermediate, is widely distributed across kingdoms, where it is synthesized notably in oil-producing species. In plants such as lavender () and citrus ( spp.), GPP serves as a primary precursor for volatiles, with synthesis occurring in glandular trichomes and secretory structures of flowers and leaves. For instance, in lavender, GPP is predominantly synthesized and utilized in floral oil glands, where activity peaks during periods of high volatile emission, contributing to the plant's characteristic scent profile. These pools are primarily localized in plastids via the methylerythritol phosphate () pathway, though minor cytosolic contributions occur through crosstalk with the , enabling flux toward diverse terpenoids. In animals, GPP exists at low, transient levels as an obligatory intermediate in the , primarily supporting and biosynthesis. It is formed by the condensation of isopentenyl pyrophosphate (IPP) and (DMAPP) via geranyl pyrophosphate synthase (GPPS), with expression regulated in specific tissues such as the of like bark beetles (Ips pini), where it serves as the direct precursor for pheromones. Overall abundance remains minimal due to rapid downstream conversion, preventing significant accumulation in mammalian or other systems during synthesis. Microbial production of GPP varies by domain and pathway, typically as a short-lived intermediate. In , GPP is generated transiently through the pathway from pyruvate and glyceraldehyde-3-phosphate, serving as a building block for ubiquinone, , and components without substantial buildup. , conversely, rely on a modified for GPP synthesis, using it to elongate into geranylgeranyl chains for membranes, again with low steady-state levels due to efficient enzymatic turnover. Engineered microbial strains, such as modified with overexpressed GPPS and synthase, increase flux through GPP to enhance yields such as , far exceeding natural microbial concentrations. Detection of GPP in biological samples relies on advanced techniques, including liquid chromatography-high-resolution (LC-HRMS) coupled with for quantification. Stable isotope labeling, such as with uniformly ^{13}C-glucose, enables profiling to track GPP flux and pool sizes, with limits of detection as low as 0.01 pmol and linear quantification up to 50 pmol. Sample via fast followed by in isopropanol-water buffers preserves labile pyrophosphates, allowing precise of plastidial or cytosolic fractions in and microbes. Ecologically, GPP underpins plant defense by fueling the of volatile terpenoids that deter herbivores and recruit beneficial predators. In response to herbivory, GPP-derived monoterpenes like and are emitted from damaged tissues, signaling neighboring plants to prime defenses or attracting parasitoids such as wasps that target pests on crops like . This indirect defense mechanism enhances ecosystem resilience, with GPP's role in the pathway ensuring rapid volatile production during stress.

Synthetic Methods

Geranyl pyrophosphate (GPP) can be synthesized chemically from through a two-step process involving chlorination followed by . In the first step, is converted to geranyl chloride using N-chlorosuccinimide and in at low temperature, yielding geranyl chloride in 93% efficiency. The geranyl chloride is then reacted with tris(tetrabutylammonium) hydrogen pyrophosphate in at to form the diphosphate, which is subsequently purified to the trisammonium salt. This method achieves an overall yield of approximately 80% from and avoids the low yields and side products associated with earlier approaches using pyrophosphoryl chloride directly on alcohols. Biocatalytic production of GPP relies on recombinant geranyl diphosphate (GPPS), which catalyzes the head-to-tail condensation of isopentenyl diphosphate () and dimethylallyl diphosphate (DMAPP). In synthesis involves expressing GPPS genes, such as the small subunit from ( spicata) or animal orthologs like the one from (Bemisia tabaci), in , followed by purification and incubation with IPP and DMAPP substrates. These recombinant enzymes produce GPP with high specificity, often exceeding 90% conversion efficiency in optimized assays. For microbial , engineered hosts like E. coli or are used, where GPPS is overexpressed alongside pathways supplying IPP and DMAPP, such as the mevalonate or methylerythritol phosphate routes, sometimes supplemented with external feeds of the precursors. This approach has enabled GPP accumulation in cell lysates, though direct isolation remains challenging due to . Recent advances as of 2023 include optimized fusion enzymes and pathway balancing to improve monoterpenoid precursor flux in microbial cell factories. Scaling up GPP production faces key challenges, including its chemical instability, as the pyrophosphate linkage hydrolyzes readily in aqueous conditions, leading to geraniol formation. Chemical synthesis scales well in laboratory settings with multi-gram yields, but industrial adaptation requires inert atmospheres and low temperatures to maintain integrity. Biocatalytic methods in microbial systems improve productivity through controlled IPP/DMAPP supplementation. Purification typically employs ion-exchange chromatography on resins like Dowex AG 50W-X8, followed by precipitation with organic solvents such as acetonitrile/isopropyl alcohol mixtures, achieving recoveries of 80–90%. Historical methods for GPP preparation date back to the mid-20th century, relying on extractions from tissues or crude chemical condensations, which often yielded impure mixtures contaminated by products. Post-2000 advances in , including recombinant GPPS expression and pathway engineering, have shifted toward sustainable, enzyme-driven production, surpassing early chemical routes in specificity and environmental compatibility. Purity standards for GPP vary by application: research-grade material, often as or salts, requires ≥95% purity by or HPLC to ensure accurate enzymatic assays, with impurities like unreacted precursors below 1%. Commercial preparations for uses demand similar high purity to avoid inhibiting downstream synthases, typically verified by NMR and .

Precursor Molecules

Isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) serve as the immediate C5 precursors to geranyl pyrophosphate in isoprenoid biosynthesis, functioning as the fundamental building blocks for all terpenoids. IPP, with its structure featuring a terminal and a group, acts as the nucleophilic donor unit that extends the prenyl chain. DMAPP, an of IPP, provides the electrophilic allylic starter unit essential for initiating condensation reactions. These molecules are present in virtually all organisms and are interconvertible, with DMAPP primarily formed through the reversible of IPP catalyzed by (IDI). The structural relationship between IPP and DMAPP enables their head-to-tail linkage, where the C1 position of DMAPP (the "head") bonds to the C4 position of IPP (the "tail"), releasing and forming a new trans . This mechanism inherits the of the precursor double bonds, maintaining the characteristic E-configuration in the resulting linear chain and ensuring geometric uniformity in downstream isoprenoids. The allylic nature of DMAPP facilitates this SN1-like displacement, with the positive charge delocalized across its system during the . IPP and DMAPP originate from two independent biosynthetic routes conserved across taxa: the in eukaryotes and some , which converts three units of to via intermediates; and the methylerythritol phosphate () pathway in plastids, , and most , starting from glyceraldehyde-3-phosphate and pyruvate to yield 1-deoxy-D-xylulose 5-phosphate as the first committed intermediate. These pathways provide the necessary pool of precursors, with IDI ensuring balanced IPP/DMAPP ratios for efficient chain elongation. Rare structural analogs, such as lavandulyl pyrophosphate, arise from atypical condensations of and DMAPP, producing branched C10 variants observed in select monoterpenoids like lavandulol.

Derivative Isoprenoids

Geranyl pyrophosphate (GPP) serves as a central in the of longer-chain isoprenoids through enzymatic chain elongation. (FPP, C15), a key precursor, is formed by the action of farnesyl pyrophosphate synthase (FPPS), which catalyzes the condensation of GPP with an additional molecule of isopentenyl (IPP). This reaction extends the prenyl chain by one unit, producing FPP as a for downstream synthesis and other metabolic processes. FPPS exhibits a sequential where the allylic (GPP) binds first, followed by IPP, leading to the release of and formation of the new C-C bond. Further extension of the chain yields (GGPP, C20), primarily through the activity of geranylgeranyl pyrophosphate synthase (GGPPS), which adds another IPP unit to FPP. GGPP acts as the foundational precursor for diterpenes, including in and in animals, as well as and other polyprenylated compounds. In some organisms, such as and , GGPPS can directly utilize shorter chains like GPP under specific conditions, but the predominant pathway involves stepwise elongation via FPP. This C20 intermediate is crucial for the structural diversity of diterpenoids, which exhibit roles in growth regulation and defense. Beyond backbones, GPP-derived compounds participate in protein post-translational modifications, particularly , which anchors proteins to membranes for signaling functions. Although GPP can theoretically enable geranylation (C10 attachment), this is rare in eukaryotic systems; instead, predominantly involves farnesylation with FPP or geranylgeranylation with GGPP. For example, G-protein γ-subunits and Rho family such as RhoA undergo geranylgeranylation using GGPP, facilitating their localization to the plasma membrane and activation in cytoskeletal regulation, , and vesicular trafficking. Disruption of this geranylgeranylation impairs Rho-mediated signaling pathways, highlighting its specificity. GPP also contributes to monoterpene formation (C10) through or cyclization. For instance, of GPP by geraniol synthase yields , a volatile with antimicrobial properties found in essential oils of like lemongrass and . In contrast, FPP-derived (C15), such as or cyclic forms like , arise from and cyclization reactions catalyzed by sesquiterpene synthases, serving roles in plant defense and aroma compounds. The chain length influences ; shorter C10 monoterpenes like exhibit higher volatility and moderate toxicity to microbes, whereas longer C15 sesquiterpenes from FPP display enhanced membrane permeability and potent effects, with geranylgeranylated derivatives showing greater in cancer cells due to altered specificity.

Research and Applications

Historical Discovery

Geranyl pyrophosphate (GPP), an essential intermediate in isoprenoid biosynthesis, was first identified in the late 1950s during investigations into the for and synthesis. Pioneering work by Feodor Lynen and Konrad Bloch, who shared the 1964 Nobel Prize in Physiology or Medicine for their discoveries on metabolism, revealed GPP as the product of head-to-tail condensation between and isopentenyl pyrophosphate. In 1958–1959, Lynen's laboratory isolated and characterized GPP enzymatically from yeast extracts, confirming its role as a C10 precursor to longer-chain isoprenoids like . This breakthrough built on earlier 1950s studies by Bloch on incorporation into and Lynen's elucidation of as the pathway's starting unit. Key milestones in the 1960s included the development of enzymatic assays that validated GPPS activity, the enzyme catalyzing GPP formation. In 1966, researchers purified and characterized GPPS from pig liver, demonstrating its specificity for producing the trans isomer of GPP and distinguishing it from downstream farnesyl pyrophosphate synthase. Complementary stereochemical studies by John Cornforth and George Popják during this decade clarified the reaction mechanism, showing inversion at the allylic carbon during condensation, which informed broader understanding of terpenoid assembly. These efforts established GPP's foundational position in the mevalonate-dependent route, with seminal papers such as Lynen's 1959 review in Angewandte Chemie outlining the pathway's intermediates. The 1980s marked advances in , including the of prenyl synthase s that extended knowledge of GPP-related enzymes; for example, the farnesyl pyrophosphate synthase was cloned in 1989, enabling and functional studies. for the compound evolved from "geranyl pyrophosphate" in early biochemical to "geranyl diphosphate" (GDP) in modern contexts, reflecting its diphosphate structure and alignment with isopentenyl diphosphate conventions. However, early research overlooked an alternative for isoprenoid precursors, the 2-C-methyl-D-erythritol 4-phosphate () route, which was not discovered until the 1990s through labeling experiments by Michel Rohmer and colleagues in and .

Modern Uses in Biotechnology

In metabolic engineering, geranyl pyrophosphate (GPP) serves as a critical precursor for monoterpene biosynthesis, with overexpression or modification of geranyl pyrophosphate synthase (GPPS) in microbial hosts enabling enhanced production of valuable compounds. In Saccharomyces cerevisiae, engineering the endogenous farnesyl pyrophosphate synthase (Erg20p) into a GPPS variant has significantly increased monoterpene titers, such as geraniol and limonene, by redirecting flux from farnesyl pyrophosphate toward the C10 pathway, achieving up to 3.4-fold improvements in yields for potential use in biofuels and flavors. Similar strategies in Escherichia coli involve bioprospecting GPPS enzymes and optimizing flux through the methylerythritol phosphate pathway, resulting in gram-per-liter production of geraniol, a key fragrance ingredient, while addressing precursor imbalances. These approaches prioritize compartmentalization and dynamic regulation to minimize competition with native pathways, supporting scalable production for industrial applications. In , 2010s research highlighted GPP's toxicity in microbial hosts, where accumulation disrupts membrane integrity and growth, prompting strategies like dominant-negative GPPS mutants to control flux and prevent buildup during synthesis. Flux optimization in E. coli using machine learning-guided translational control of GPPS and downstream synthases has enabled predictive chassis design, boosting titers by over 100-fold while mitigating through esterification or export mechanisms. These tools have facilitated orthogonal pathways in , decoupling production from endogenous metabolism for applications in microbial control and high-value . Industrial examples include the use of engineered yeast strains overexpressing GPPS to produce precursors, where balanced IPP/DMAPP pools enhance amorphadiene yields from downstream , contributing to semi-synthetic antimalarial production. For fragrances, GPPS engineering in S. cerevisiae and E. coli has scaled output to levels suitable for commercial flavor and perfume industries, with titers exceeding 1 g/L in optimized fermentations. Pharmaceutically, GPP's role in the pathway positions upstream inhibitors, such as statins targeting , as candidates for cancer therapy by depleting isoprenoid pools and blocking protein farnesylation/geranylgeranylation essential for tumor signaling. Similarly, inhibitors of related like synthase exhibit effects by disrupting in pathogens, with potential extensions to GPPS modulation for controlling bacterial prenylation-dependent . Future prospects involve CRISPR-based edits for precise pathway tuning, such as multiplexed activation of GPPS in plants to redirect flux toward sustainable monoterpene synthesis, alongside 2020s advances in yeast platforms achieving universal terpenoid production through modular synthetic operons. As of 2025, advances in microbial production of geraniol include engineered Escherichia coli strains achieving 13.2 g/L and Saccharomyces cerevisiae 5.5 g/L, supporting industrial scale-up for sustainable terpenoid synthesis. These developments promise eco-friendly bioproduction, reducing reliance on chemical extraction for pharmaceuticals and biofuels.

References

  1. [1]
    Geranyl Diphosphate: Uses, Interactions, Mechanism of Action
    Jun 13, 2005 · Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid ...
  2. [2]
    Crystal Structure of Geranylgeranyl Pyrophosphate Synthase (CrtE ...
    May 24, 2020 · Prenyltransferase enzymes catalyze the initial condensation reaction between IPP and DMAPP to give C10-geranyl pyrophosphate (GPP), plus the ...
  3. [3]
    Geranylgeranyl Pyrophosphate - an overview | ScienceDirect Topics
    Geranylgeranyl pyrophosphate (GGPP) is defined as an isoprenoid intermediate in the cholesterol biosynthesis pathway that plays a role in post-translational ...
  4. [4]
    Geranyl Diphosphate
    Insufficient relevant content. The provided text only includes a PubChem identifier (CID 445995), molecular formula (C10H20O7P2), and a reference to Geranyl Diphosphate, along with a JavaScript requirement notice and a logo. No detailed information on molecular weight, IUPAC name, other names, or structure description (carbon chain, double bonds, configuration, pyrophosphate group) is present.
  5. [5]
  6. [6]
  7. [7]
  8. [8]
    Hydrolysis of nucleoside phosphates. 6. The mechanism of the ...
    Enhancement of the hydrolysis of geranyl pyrophosphate by bivalent metal ions. A model for enzymic biosynthesis of cyclic monoterpenes. Tetrahedron 1981, 37 ...
  9. [9]
    pH-dependent leaving group effects on hydrolysis reactions of ...
    The other preferred pyrophosphate esters of primary allylic alcohols such as geranyl pyrophosphate and neryl pyrophosphate, which are precursors of cyclic ...Missing: degradation | Show results with:degradation
  10. [10]
    trisammonium geranyl diphosphate - Organic Syntheses Procedure
    The IR, 1H NMR, and 13C NMR spectra of this material are identical to those for distilled geranyl chloride (bp 49–51°C at 0.2 mm). Distillation on a small scale ...
  11. [11]
    Synthesis of geranyl pyrophosphate (GPP) in plants - ResearchGate
    The present review highlights the Foeniculum vulgare essential oil extraction process, chemical composition, and various applications with the biological ...
  12. [12]
    Geranyl diphosphate synthase: Cloning, expression, and ... - PNAS
    Geranyl diphosphate synthase, which catalyzes the condensation of dimethylallyl diphosphate and isopentenyl diphosphate to geranyl diphosphate,Missing: review | Show results with:review
  13. [13]
    Structure, mechanism and function of prenyltransferases - FEBS Press
    Jul 4, 2002 · This enzyme catalyzes the transfer of the carbon moiety of FPP or GGPP to a conserved cysteine residue in a CaaX motif of protein and peptide ...<|control11|><|separator|>
  14. [14]
    Structure of a Heterotetrameric Geranyl Pyrophosphate Synthase ...
    This work presents the crystal structure of mint heteromeric prenyltransferase, which is responsible for the biosynthesis of geranyl pyrophosphate.
  15. [15]
    A cytosolic bifunctional geranyl/farnesyl diphosphate synthase ... - NIH
    May 1, 2023 · A cytosolic bifunctional geranyl/farnesyl diphosphate synthase provides MVA-derived GPP for geraniol biosynthesis in rose flowers.
  16. [16]
    Isolation and functional expression of an animal geranyl ... - PNAS
    Geranyl diphosphate synthase (GPPS) catalyzes the condensation of dimethylallyl diphosphate and isopentenyl diphosphate to form geranyl diphosphate.
  17. [17]
    A Bifunctional Geranyl and Geranylgeranyl Diphosphate Synthase Is ...
    A bifunctional geranyl and geranylgeranyl diphosphate synthase is involved in terpene oleoresin formation in picea abies.
  18. [18]
    Two-step pathway for isoprenoid synthesis - PMC - PubMed Central
    Dec 24, 2018 · The mevalonate (MVA) pathway involves seven reactions to produce IPP from acetyl-CoA. DMAPP is then produced through the isomerization of IPP by ...
  19. [19]
    Distinct Light-Mediated Pathways Regulate the Biosynthesis and ...
    The plastidial MEP pathway produces IPP and DMAPP for the biosynthesis of photosynthesis-related isoprenoids (carotenoids and the side chains of chlorophylls, ...Missing: pyrophosphate | Show results with:pyrophosphate
  20. [20]
    The MEP pathway: Promising drug targets in the fight against ...
    The MEP pathway consists of seven enzymatic steps starting from pyruvate (Pyr) and Dglyceraldehyde-3-phosphate (D-GAP) to produce IPP and DMAPP (Figure 2).
  21. [21]
    Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid ...
    Jan 25, 2013 · A key enzyme in this pathway is farnesyl pyrophosphate (EC 2.5.1.10) synthase (FPPS) which supplies precursors for the biosynthesis of essential isoprenoids.Missing: geranyl | Show results with:geranyl
  22. [22]
  23. [23]
    Genomic insights into the evolution of hybrid isoprenoid biosynthetic ...
    Nov 17, 2015 · One hundred and twenty Streptomyces genomes were searched for HI biosynthetic gene clusters using ABBA prenyltransferases (PTases) as queries.
  24. [24]
    Structure, catalysis, and inhibition mechanism of prenyltransferase
    Productions of isoprenoids are catalyzed by a group of enzymes known as prenyltransferases, such as farnesyltransferases, geranylgeranyltransferases, terpenoid ...
  25. [25]
    The functional evolution of architecturally different plant geranyl ...
    In plants, GPP is predominantly produced in plastids for the biosynthesis of monoterpenes, which are major constituents of plant volatiles, while FPP is ...
  26. [26]
  27. [27]
    Discovery and biological characterization of geranylated RNA ... - NIH
    coli, and purified SelU protein in the presence of geranyl pyrophosphate and tRNA can produce geranylated tRNA. The presence or absence of the geranyl group ...
  28. [28]
  29. [29]
  30. [30]
  31. [31]
  32. [32]
  33. [33]
  34. [34]
  35. [35]
    Natural Compounds in the Battle against Microorganisms—Linalool
    Oct 15, 2022 · In plants, linalool is made from geranyl pyrophosphate (GPP)—a ... Lavender essential oil and its main constituents inhibit the ...
  36. [36]
  37. [37]
  38. [38]
  39. [39]
    Biosynthesis of archaeal membrane ether lipids - Frontiers
    In general, IPP and DMAPP are synthesized by the MEP pathway in most of the bacteria and by two MVA pathways in eukarya and archaea. The classical MVA pathway ...
  40. [40]
  41. [41]
    Functional analysis of isoprenoid precursors biosynthesis by ... - NIH
    Aug 21, 2019 · IPP is isomerized into dimethylallyl diphosphate (DMAPP), which is then condensed with IPP to generate geranyl pyrophosphate (GPP). Longer ...
  42. [42]
  43. [43]
    US8715962B2 - Production of geranyl diphosphate - Google Patents
    In one biosynthetic pathway, GPP is produced from the five-carbon precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).
  44. [44]
  45. [45]
    The Non-mevalonate Pathway of Isoprenoid Precursor Biosynthesis
    Isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) are the universal precursors of natural products called isoprenoids. This large family, ...
  46. [46]
    Differential expression of two isopentenyl pyrophosphate ... - PNAS
    The enzyme isopentenyl pyrophosphate (IPP) isomerase catalyzes the reversible isomerization of IPP to produce dimethylallyl pyrophosphate, the initial ...
  47. [47]
    Isoprenoids in three-dimensional space: the stereochemistry of ...
    Oct 7, 2011 · This review summarises the accumulated knowledge about the stereochemical courses of biosynthetic reactions to isoprenoids . Important pathways ...Missing: inheritance head- tail linkage
  48. [48]
    Towards efficient terpenoid biosynthesis: manipulating IPP and ...
    Feb 6, 2019 · We first introduce biosynthetic pathways of IPP and DMAPP, and then summarize the current strategies adopted for manipulating IPP and DMAPP supply.Missing: delta | Show results with:delta<|separator|>
  49. [49]
    ENZYMES OF THE MEVALONATE PATHWAY OF ISOPRENOID ...
    The mevalonate pathway accounts for conversion of acetyl-CoA to isopentenyl 5-diphosphate, the versatile precursor of polyisoprenoid metabolites and natural ...
  50. [50]
    The Multifaceted MEP Pathway: Towards New Therapeutic ... - NIH
    Moreover, the impact of the double bond configuration of the isoprene unit has been studied, and the PAgs in their natural E configuration turned out to be ...
  51. [51]
    Synthetic Biology, Combinatorial Biosynthesis, and Chemo ...
    For example, there are four possible C10 linear monoterpenes produced from DMAPP/IPP: GPP, NPP (the cis conformer of GPP), lavandulyl pyrophosphate, made from a ...
  52. [52]
    Investigation of the catalytic mechanism of farnesyl pyrophosphate ...
    Farnesyl pyrophosphate synthase (FPPS) catalyses the formation of a key cellular intermediate in isoprenoid metabolic pathways, farnesyl pyrophosphate, ...
  53. [53]
    Geranylgeranyl diphosphate synthase: Role in human health ...
    Jan 17, 2023 · Geranylgeranyl diphosphate synthase (GGDPS), an enzyme in the isoprenoid biosynthesis pathway, is responsible for the production of geranylgeranyl ...
  54. [54]
    Inhibition of protein geranylgeranylation and RhoA/RhoA kinase ...
    Geranylgeranylation of RhoA small G-protein is essential for its localization to cell membranes and for its biological functions. Many RhoA effects are ...Missing: geranylation geranyl
  55. [55]
    De novo production of six key grape aroma monoterpenes by ... - NIH
    This metabolic manipulation was possible because plant MTPSs catalyze the synthesis of monoterpenes from geranyl pyrophosphate (GPP) in a single step, and S.
  56. [56]
    A Novel Pathway for Sesquiterpene Biosynthesis from Z,Z-Farnesyl ...
    It has been found to date that the biosynthesis of terpenoids proceeds from IPrPs in the E configuration via the action of a conserved family of enzymes, the ...Missing: geranyl | Show results with:geranyl
  57. [57]
    [PDF] Konrad Bloch - The biological synthesis of cholesterol - Nobel Prize
    The discovery of geranylpyrophosphate53 and of farnesylpyro- phosphate50 in Lynen's laboratory completed the description of the biosyn- thetic pathway and of ...Missing: geranyl | Show results with:geranyl
  58. [58]
    The purification and properties of pig liver geranyl pyrophosphate ...
    The purification and properties of pig liver geranyl pyrophosphate synthetase. J Biol Chem. 1966 Nov 25;241(22):5353-60. Authors. J K Dorsey, J A Dorsey, J W ...
  59. [59]
    The Purification and Properties of Pig Liver Geranyl Pyrophosphate ...
    The purification and properties of geranyl pyrophosphate synthetase are reported. This enzyme is purified simultaneously with the enzyme for the synthesis ...<|control11|><|separator|>
  60. [60]
    The discovery of a mevalonate-independent pathway for isoprenoid ...
    The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat Prod Rep. 1999 Oct;16(5):565-74.Missing: MEP 1990s
  61. [61]
    Engineering Monoterpene Production in Yeast Using a Synthetic ...
    We engineered Erg20p into a geranyl diphosphate synthase and achieved a significant increase in monoterpene titers.
  62. [62]
    Orthogonal monoterpenoid biosynthesis in yeast constructed on an ...
    Aug 23, 2019 · Therefore, Erg20p is very efficient in utilizing GPP, reducing the GPP pool and hindering monoterpene production. Thus, we set out to engineer ...
  63. [63]
    Engineering Escherichia coli for production of geraniol by systematic ...
    Since toxic IPP is the precursor for GPP, growth inhibition could be effectively alleviated by GPPS overexpression. On the other hand, the upregulation of GPPS ...
  64. [64]
    Synthetic and systems biology for microbial production of commodity ...
    Apr 7, 2016 · The toxicity of these compounds was evaluated using strains that accumulate isopentenyl pyrophosphate, GPP, and FPP, and the accumulation of FPP ...
  65. [65]
    Machine Learning of Designed Translational Control Allows ...
    Dec 18, 2018 · This methodology is potentially compatible with any biochemical pathway and provides a powerful tool toward predictive design of bacterial production chassis.
  66. [66]
    Engineering Saccharomyces cerevisiae for the production of the ...
    Jun 5, 2018 · Some reports also demonstrated the potential of metabolic engineering for monoterpene production in S. cerevisiae [18]. GPP is synthesized by ...
  67. [67]
    A Novel Semi-biosynthetic Route for Artemisinin Production Using ...
    Mar 9, 2009 · Because isopentenyl and dimethylallyl pyrophosphates are the universal precursors to all isoprenoids, the strains developed in this study can ...
  68. [68]
    Efficient production of (S)-limonene and geraniol in Saccharomyces ...
    We generated a novel Erg20 WWG mutant with over four times higher GPP accumulating capability than Erg20 WW, as observed through geraniol production levels.<|control11|><|separator|>
  69. [69]
    Isoprenoids responsible for protein prenylation modulate the ...
    Dec 20, 2017 · Our data indicate that the anticancer effects of statins observed in numerous studies to a large extent are mediated through isoprenoid intermediates of the ...
  70. [70]
    Characterization of Potential Drug Targets Farnesyl Diphosphate ...
    We report here that Schistosoma mansoni farnesyl diphosphate synthase (SmFPPS) and geranylgeranyl diphosphate synthase (SmGGPPS) are potential drug targets for ...
  71. [71]
    Engineering a universal and efficient platform for terpenoid ... - PNAS
    Dec 28, 2022 · Sequential addition of IPP units to DMAPP generates terpenoid precursors, like geranyl diphosphate (GPP, C10), farnesyl diphosphate (FPP, C15), ...
  72. [72]
    [PDF] Application and development of CRISPR technology in ... - Frontiers
    Jan 9, 2025 · This article introduces the principles of CRISPR technology and its efficacy in gene editing, followed by a detailed discussion of its ...Missing: geranyl | Show results with:geranyl<|control11|><|separator|>